Cargando…

A novel epithelial‐mesenchymal transition molecular signature predicts the oncological outcomes in colorectal cancer

Epithelial‐mesenchymal transition (EMT), a biological process involving the transformation of epithelial cells into mesenchymal cells, promotes tumour initiation and metastasis. The aim of this study was to construct an EMT molecular signature for predicting colorectal cancer (CRC) prognosis and eva...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shan, Zezhi, Wu, Wen, Yan, Xuebing, Yang, Yongzhi, Luo, Dakui, Liu, Qi, Li, Xinxiang, Goel, Ajay, Ma, Yanlei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8034457/ https://www.ncbi.nlm.nih.gov/pubmed/33660944 http://dx.doi.org/10.1111/jcmm.16387

Ejemplares similares

Proteomic profiling reveals a signature for optimizing prognostic prediction in Colon Cancer
por: Shan, Zezhi, et al.
Publicado: (2021)

A Novel Seventeen-Gene Metabolic Signature for Predicting Prognosis in Colon Cancer
por: Luo, Dakui, et al.
Publicado: (2020)

The correlation between tumor size, lymph node status, distant metastases and mortality in rectal cancer patients without neoadjuvant therapy
por: Luo, Dakui, et al.
Publicado: (2021)

Evaluation of Traditional Prognostic Factors for Stage I-III Colorectal Cancer Patients Who Survived for Over Five Years After Surgery
por: Luo, Dakui, et al.
Publicado: (2021)

Clinicopathological Features of Stage I–III Colorectal Cancer Recurrence Over 5 Years After Radical Surgery Without Receiving Neoadjuvant Therapy: Evidence From a Large Sample Study
por: Luo, Dakui, et al.
Publicado: (2021)

PROX1 restrains ferroptosis via SCD transcription activation in colorectal cancer: PROX1 inhibits ferroptosis in CRC
por: Zhang, Ruoxin, et al.
Publicado: (2023)

Palliative beam radiotherapy offered real-world survival benefit to metastatic rectal cancer: A large US population-based and propensity score-matched study
por: Liu, Qi, et al.
Publicado: (2019)

Associations of P Score With Real-World Survival Improvement Offered by Adjuvant Chemotherapy in Stage II Colon Cancer: A Large Population-Based Longitudinal Cohort Study
por: Liu, Qi, et al.
Publicado: (2021)

CUL4B-DDB1-COP1-mediated UTX downregulation promotes colorectal cancer progression
por: Luo, Dakui, et al.
Publicado: (2023)

circCAPRIN1 interacts with STAT2 to promote tumor progression and lipid synthesis via upregulating ACC1 expression in colorectal cancer
por: Yang, Yufei, et al.
Publicado: (2022)

c-Myb and its Effector COX-2 as an Indicator Associated with Prognosis and Therapeutic Outcome in Colorectal Cancer
por: Xie, Ruting, et al.
Publicado: (2019)

Identification of a novel prognostic signature correlated with epithelial‐mesenchymal transition, N6‐methyladenosine modification, and immune infiltration in colorectal cancer
por: Qu, Xiao, et al.
Publicado: (2022)

Circulating basophil count as a prognostic marker of tumor aggressiveness and survival outcomes in colorectal cancer
por: Liu, Qi, et al.
Publicado: (2020)

Survival Benefit of Preoperative Versus Postoperative Radiotherapy in Metastatic Rectal Cancer Treated With Definitive Surgical Resection of Primary Tumor: A Population Based, Propensity Score-Matched Study
por: Luo, Dakui, et al.
Publicado: (2019)

Molecular and pathological signatures of epithelial–mesenchymal transitions at the cancer invasion front
por: De Wever, Olivier, et al.
Publicado: (2008)

N(6)-methyladenosine as a biological and clinical determinant in colorectal cancer: progression and future direction
por: Li, Jinming, et al.
Publicado: (2021)

Integrated microbiome and metabolome analysis reveals a novel interplay between commensal bacteria and metabolites in colorectal cancer
por: Yang, Yongzhi, et al.
Publicado: (2019)

Effect of interval between neoadjuvant chemoradiotherapy and surgery on oncological outcomes in poor responders with locally advanced rectal cancer: a retrospective cohort study
por: Luo, Dakui, et al.
Publicado: (2023)

Evaluating the Guiding Role of Elevated Pretreatment Serum Carcinoembryonic Antigen Levels for Adjuvant Chemotherapy in Stage IIA Colon Cancer: A Large Population-Based and Propensity Score-Matched Study
por: Liu, Qi, et al.
Publicado: (2019)

Role of Epithelial to Mesenchymal Transition in Colorectal Cancer
por: Lu, Jian, et al.
Publicado: (2023)

Loss of Yes-associated Protein Represents an Aggressive Subtype of Colorectal Cancer
por: Zhang, Sheng, et al.
Publicado: (2019)

Epithelial‐to‐mesenchymal transition signature assessment in colorectal cancer quantifies tumour stromal content rather than true transition
por: McCorry, Amy MB, et al.
Publicado: (2018)

Human oral microbiome dysbiosis as a novel non-invasive biomarker in detection of colorectal cancer
por: Zhang, Sheng, et al.
Publicado: (2020)

Dysbiosis of human gut microbiome in young-onset colorectal cancer
por: Yang, Yongzhi, et al.
Publicado: (2021)

Characterization of the fatty acid metabolism in colorectal cancer to guide clinical therapy
por: Ding, Chengsheng, et al.
Publicado: (2021)

Proteomic Technology “Lens” for Epithelial-Mesenchymal Transition Process Identification in Oncology
por: Neagu, Monica, et al.
Publicado: (2019)

Assessment of epithelial–mesenchymal transition signatures in oral submucous fibrosis
por: Prasad, R Shesha, et al.
Publicado: (2019)

c‐Myb promotes growth and metastasis of colorectal cancer through c‐fos‐induced epithelial‐mesenchymal transition
por: Qu, Xiao, et al.
Publicado: (2019)

Klotho negatively regulated aerobic glycolysis in colorectal cancer via ERK/HIF1α axis
por: Li, Qingguo, et al.
Publicado: (2018)

Clinical significance of Fusobacterium nucleatum, epithelial–mesenchymal transition, and cancer stem cell markers in stage III/IV colorectal cancer patients
por: Yan, Xuebing, et al.
Publicado: (2017)

Sciellin mediates mesenchymal-to-epithelial transition in colorectal cancer hepatic metastasis
por: Chou, Chuan-Kai, et al.
Publicado: (2016)

ACRNaCT trial protocol: efficacy of adjuvant chemotherapy in patients with clinical T3b/T4, N+ rectal Cancer undergoing Neoadjuvant Chemoradiotherapy: a pathology-oriented, prospective, multicenter, randomized, open-label, parallel group clinical trial
por: Li, Qingguo, et al.
Publicado: (2019)

An individualized transcriptional signature to predict the epithelial-mesenchymal transition based on relative expression ordering
por: Chen, Tingting, et al.
Publicado: (2020)

GGCT promotes colorectal cancer migration and invasion via epithelial-mesenchymal transition
por: Huang, Qi, et al.
Publicado: (2020)

LIM protein JUB promotes epithelial–mesenchymal transition in colorectal cancer
por: Liang, Xing-Hua, et al.
Publicado: (2014)

Epithelial–Mesenchymal Transition Gene Signature Related to Prognostic in Colon Adenocarcinoma
por: Busuioc, Constantin, et al.
Publicado: (2021)

Immunohistochemical-based molecular subtyping of colorectal carcinoma using maspin and markers of epithelial-mesenchymal transition
por: Banias, Laura, et al.
Publicado: (2020)

Transcriptomic expression profiling identifies ITGBL1, an epithelial to mesenchymal transition (EMT)-associated gene, is a promising recurrence prediction biomarker in colorectal cancer
por: Matsuyama, Takatoshi, et al.
Publicado: (2019)

Downregulation of iNOS/NO Promotes Epithelial–Mesenchymal Transition and Metastasis in Colorectal Cancer
por: Du, Qiang, et al.
Publicado: (2023)

TRIM37 promotes epithelial-mesenchymal transition in colorectal cancer
por: Hu, Cheng-En, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_pu4l6c3hss3t6ud1o4efpld54g